Vanguard Group Inc Virios Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 208,883 shares of VIRI stock, worth $927,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208,883
Previous 208,883
-0.0%
Holding current value
$927,440
Previous $45,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIRI
# of Institutions
28Shares Held
1.12MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA231KShares$1.02 Million0.0% of portfolio
-
Ubs Group Ag186KShares$826,1150.0% of portfolio
-
Hrt Financial LP New York, NY81.6KShares$362,1880.0% of portfolio
-
Two Sigma Securities, LLC New York, NY53.4KShares$237,0600.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$234,5560.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $81.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...